The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


HUMALOG MIX50

100 Units/ml Suspension for Injection

Eli Lilly Nederland B.V.EU/1/96/007/006

Main Information

Trade NameHUMALOG MIX50
Active SubstancesINSULIN LISPRO
Strength100 Units/ml
Dosage FormSuspension for Injection
Licence HolderEli Lilly Nederland B.V.
Licence NumberEU/1/96/007/006

Group Information

ATC CodeA10AD04 insulin lispro

Status

Authorised/WithdrawnAuthorised
Licence Issued19/11/1998
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back